H-NQEQVSPLTLLK-OH

Ref. 3D-PP42624

Informations sur le produit

• Nom: H-NQEQVSPLTLLK-OH

Description

Peptide H-NQEQVSPLTLLK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NQEQVSPLTLLK-OH include the following: alpha2-Plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study Z Hevessy , A Patthy, L Karpati - Thrombosis , 2000 - thrombosisresearch.comhttps://www.thrombosisresearch.com/article/S0049-3848(00)00261-9/abstract Protein-peptide based assay for the characterization of human blood coagulation factor XIII-A isopeptidase activity Z Csoban-Szabo, L Fesus , R Kiraly - Analytical biochemistry, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003269720302311 Application of Near-Infrared Fluorescence Imaging in Thrombosis Detection W Zhang, M Li, X Wang , P Li , B Tang - Analysis & Sensing, 2023 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/anse.202200045 Comparative Structural and Functional Features of the Human Fibrinogen alphaC Domain and the Isolated alphaC Fragment: CHARACTERIZATION USING MONOCLONAL S Rudchenko, I Trakht, JH Sobel - Journal of Biological Chemistry, 1996 - ASBMBhttps://www.jbc.org/article/S0021-9258(17)45701-2/abstract Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters R Kiraly , K Thangaraju , Z Nagy, R Collighan, Z Nemes - Amino acids, 2016 - Springerhttps://link.springer.com/article/10.1007/s00726-015-2063-5 EVALUATION OF A NEW RABBIT BRAIN THROMBOPLASTIN, DIA PT (DIAGON, HUNGARY) QOF D-DIMER - degruyter.comhttps://www.degruyter.com/document/doi/10.1515/CCLM.2007.208/html Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction M Nahrendorf , K Hu, S Frantz , FA Jaffer , CH Tung - Circulation, 2006 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/circulationaha.105.602094 Development and preclinical validation of molecular and nanoparticulate probes for imaging of fibrin LWE Starmans - 2014 - research.tue.nlhttps://research.tue.nl/files/48404357/20161218_Starmans.pdf Factor XIII: structure, activation, and interactions with fibrinogen and fibrin L Lorand - Annals of the New York Academy of Sciences, 2001 - Wiley Online Libraryhttps://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1749-6632.2001.tb03516.x Modulating the adhesive strength of blood clots by coagulation factor XIIIa-based technologies KYT Chan - 2019 - open.library.ubc.cahttps://open.library.ubc.ca/soa/cIRcle/collections/ubctheses/24/items/1.0381039 A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion KN Lee, KW Jackson, VJ Christiansen, KH Chung - Blood, 2004 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/103/10/3783/17654 A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma K Oertel, A Hunfeld, E Specker, C Reiff, R Seitz - Analytical , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003269707003119 Preferred substrate sequences for transglutaminase 2: screening using a phage-displayed peptide library K Hitomi, M Kitamura, Y Sugimura - Amino acids, 2009 - Springerhttps://link.springer.com/article/10.1007/s00726-008-0126-6 Alpha-Chain cross-linking in fibrin (ogen) Marburg JH Sobel, I Trakht, HQ Wu, S Rudchenko, R Egbring - 1995 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/86/3/989/174048 Fibrinolysis is amplified by converting alpha2-antiplasmin from a plasmin inhibitor to a substrate IY Sazonova, BM Thomas , IP Gladysheva - Journal of Thrombosis , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1538783622080114 XII International Fibrinogen Workshop Wrightsville Beach, NC, USA 29 June-2 July 1993 G Lowe - Blood Coagulation and Fibrinolysis, 1993 - journals.lww.comhttps://journals.lww.com/bloodcoagulation/citation/1993/10000/session_1_chairmen__michael_mosesson_and_gordon.21.aspx Noninvasive Integrated SPECT/CT Molecular Imaging of Activated Factor XIII Activity in Thrombosis FA Jaffer , JL Figueiredo , G Wojtkiewicz, H Zhang - 2007 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/circ.116.suppl_16.II_155-b Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination E Csosz , P Bagossi, Z Nagy, Z Dosztanyi - Journal of molecular , 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S002228360801019X Will molecular optical imaging have clinically important roles in stroke management, and how? DK Lee, M Nahrendorf , D Schellingerhout - Journal of Clinical , 2010 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851295/ Characterization of transglutaminase 2 substrate specificity using phage display technology, logistic regression analysis and intrinsic disorder examination aca‰ Csà ‘sz - dea.lib.unideb.huhttps://dea.lib.unideb.hu/server/api/core/bitstreams/20d3074e-989b-46f3-9d39-d28276defe28/content

• Marque: Biosynth